Workflow Orchestration for Neurodegenerative

Data Characteristics in this Domain

Neurodegenerative disease pharmacovigilance data primarily originates from clinical trial reports, real-world studies, spontaneous reporting systems (e.g., FDA FAERS, EMA EudraVigilance), and medical literature. Data updates frequently. During clinical trials, updates may occur weekly or monthly. After market release, data continuously flows into spontaneous reporting systems. Document structures are diverse, including unstructured free text (e.g., patient descriptions, physician diagnoses), semi-structured case report forms (CRFs), and structured coded data (e.g., MedDRA codes, WHO-DD codes). Fields and units are specialized. For example, disease progression scores (e.g., ADL, MMSE, UPDRS) include specific scale units. Adverse event descriptions often involve symptoms, signs, severity, onset time, and duration. Drug dosages are frequently expressed in milligrams (mg), micrograms (µg), or units (U), with administration frequency calculated daily, weekly, or monthly.

Constraints Imposed by these Characteristics on Workflow Orchestration

The multi-source and heterogeneous nature of neurodegenerative disease pharmacovigilance data necessitates robust data integration and preprocessing capabilities in workflow orchestration. The high proportion of unstructured text requires workflows to effectively perform Named Entity Recognition (NER) and event extraction, structuring key information such as symptoms, drugs, and dosages. High-frequency data streams demand real-time and automated workflows. For example, the system must regularly pull the latest reports from multiple data sources and trigger analysis processes. Complex fields and units, especially disease progression scales and dosage information, require fine-grained processing during data cleaning and standardization to prevent misjudgment due to unit confusion. Furthermore, the application of professional coding systems like MedDRA means workflows must integrate specialized dictionaries for accurate terminology mapping, supporting adverse reaction signal detection and analysis.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`Chunk size` (Chunk Length)	`500–800 characters`	Neurodegenerative disease pharmacovigilance reports often contain detailed disease progression descriptions and adverse event details. Increasing the chunk length helps maintain contextual completeness and prevents key information from being split.
`Recall count` (Recall Count)	`10–15 items`	Ensures sufficient relevant report segments are covered during complex adverse reaction signal detection, increasing the probability of discovering potential associations.
`Similarity threshold` (Similarity Threshold)	`0.75–0.85`	Descriptions of neurodegenerative disease adverse reactions may have subtle differences but be essentially the same. A higher threshold helps with precise matching and reduces false positives; a lower one might introduce noise. Calibration with MedDRA codes is necessary.
`Rerank result count` (Reranked Return Count)	`3–5 items`	After recall, a reranking model further filters for the most relevant report segments to the query intent, focusing on core adverse event information and reducing the model's processing burden.
`maxContext`	`4096 tokens`	Ensures enough contextual information can be accommodated during multi-turn conversations or complex queries, especially when users need to trace a specific patient's medication history and adverse reaction progression.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Clinical reports or case documents for neurodegenerative diseases can be large, containing extensive text and tabular data. A longer parsing timeout ensures large files have sufficient time for content extraction, preventing data loss due to timeouts.

Common Pitfalls

When specifying output links in the reply component, the actual display is "Click here to ask now": This occurs because the Reply Content field in the component configuration directly contains the URL, but the Return Link type is not selected. The system then identifies it as plain text and triggers default behavior.
Workflow input instructions are not recognized or respond abnormally: This often stems from the Input Instruction node not having Variable Name or Default Value correctly configured, or the Instruction Matching Rule being too broad or too strict, failing to accurately capture user intent.
The knowledge base search node cannot dynamically specify a knowledge base: This happens because the Reference Variable is empty, typically because a preceding node (e.g., User Query or Variable Setting) failed to successfully extract or set the Knowledge base ID (Knowledge Base ID) variable used for dynamic knowledge base selection.

Verification Steps

Run test cases and observe the retrieval results for specified adverse event reports. Verify that Recall count (Recall Count) and Rerank result count (Reranked Return Count) meet expectations, and check that the returned content accurately covers key symptoms and drug information.
Simulate user input to test workflows that include dynamic knowledge base selection. Confirm that the Knowledge base search (Knowledge Base Search) node correctly loads the corresponding neurodegenerative disease knowledge base based on the input variable.
Check workflow logs to confirm that PARSE_FILE_TIMEOUT_SECONDS does not cause timeout errors when processing large clinical trial reports, and that all critical information (e.g., drug dosage, MedDRA codes) has been successfully extracted and structured.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.